NEW: FDA's Julie Tierney and Dr. Nicole Verdun to Speak at ASGCT's Policy Summit (Sept. 23-24). Register Now!
March 30, 2023 | 12 - 1 p.m. CT
Kimberly Goodspeed, MD, assistant professor of pediatrics, division of neurology, UT Southwestern Medical Center
Jennifer Helfer, PhD, senior director, patient advocacy & engagement, corporate affairs at Viridian Therapeutics
Tejashri Purohit-Sheth, MD, FACAAI, CQIA, director, Division of Clinical Evaluation and Pharmacology/Toxicology, Office of Tissues and Advanced Therapies Center for Biologics Evaluation and Research, U.S. FDA
September 23-24, 2024 | Washington, D.C.
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico